UK Markets closed

Bayer Aktiengesellschaft (0P6S.IL)

IOB - IOB Delayed price. Currency in EUR
Add to watchlist
52.68+1.28 (+2.50%)
At close: 06:15PM GMT
Full screen
Previous close51.40
Open51.29
Bid52.14 x 0
Ask53.22 x 0
Day's range51.14 - 52.81
52-week range6.00 - 53.03
Volume2,087,969
Avg. volume1,658,963
Market cap52.635B
Beta (5Y monthly)1.31
PE ratio (TTM)351.20
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend date29 Apr 2013
1y target estN/A
  • Zacks

    Merck's (MRK) Chronic Cough Drug Gets CRL From FDA

    Merck's (MRK) new drug application for gefapixant to treat refractory chronic cough or unexplained chronic cough fails to secure approval from the FDA. Meanwhile, the drug secures approval in Japan.

  • Zacks

    Regeneron (REGN) Rides on Solid Product Portfolio: Should You Buy?

    Regeneron (REGN) is expected to maintain momentum on the back of a solid and diverse portfolio. The promising pipeline also sets the stage for further growth.

  • Reuters

    Investors want $2.5 billion in class action over Bayer's Monsanto deal

    Investors are demanding around 2.2 billion euros ($2.5 billion) from Bayer as part of a possible class action lawsuit in Germany over the takeover of U.S. seed manufacturer Monsanto, law firm Tilp said on Monday. The law firm said that as of Dec. 30, the sum covered lawsuits from about 320 investors, both institutional and retail, that had been filed with the district court in Cologne. This represents a significant jump from the 250-plus investors demanding damages of more than 1 billion euros that Tilp disclosed last month.